Study Title
Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer (VAPOR 2)
Purpose
The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.
For more information please visit
https://clinicaltrials.gov/study/NCT05683691
Interested in Volunteering for the Study?
If you would like more information about this study, please call us at 318-212-8130.
Eligibility
Study Process
Trial Details
Investigator:
Amit Ahuja, M.D.
IRB:
** WK New Format
IRB Number:
Trial Type:
Device
Sponsor:
** WK New Format
Contact Information:
Pinnacle Gastroenterology
(318) 212-8710
http://www.pinnaclegastroenterology.com